Paragonix Technologies, Inc. is revolutionizing the transplant journey with its innovative Organ Preservation and Transport Devices. Led by Lisa Anderson, the Cambridge-based startup has raised $24M in Series B funding with Signet Healthcare Partners as its investor. Paragonix SherpaCool™ Ribbons’ proprietary phase-change technology provides a stable temperature environment for the donor organ for over 40 hours, ensuring a consistent thermal environment for the organ during the entire transplant journey.

Paragonix's organ transport products have been positively received by cardiothoracic surgeons, with one saying, “I felt like our recipient got a Superman's heart”. Paragonix's experienced global clinical support team offers real-time support and personalized training to ensure the transplant process is seamless. Paragonix Organ Preservation and Transport Devices are validated for multiple stages of the transplant process and have been reported in the GUARDIAN Registry, an international consortium examining the effect of controlled hypothermic preservation in heart transplantation.